BYoRNA is a startup based in France, most recent round Pre-Seed, 1 tracked investor.
Based in France, BYoRNA is a startup. Its most recent tracked round is Pre-Seed. Brouky records 1 investor associated with the company.
Develops a platform for industrial in vivo production of clinical-grade messenger RNA (mRNA) for human and animal health, targeting vaccines and therapeutic applications including infectiology, oncology and rare diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.